Header Logo

Connection

Naoko Takebe to Bortezomib

Back to Details
This is a "connection" page, showing publications Naoko Takebe has written about Bortezomib.
Naoko Takebe
Connection Strength
0.061
Bortezomib
  1. Phase I trial of the combination of bortezomib and clofarabine in adults with refractory tumors. Cancer Chemother Pharmacol. 2026 Mar 14; 96(1).
    View in: PubMed
    Score: 0.061
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.